These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10335695)

  • 1. Weight watching in heparin.
    Cheng TO
    Arch Intern Med; 1999 May; 159(10):1142. PubMed ID: 10335695
    [No Abstract]   [Full Text] [Related]  

  • 2. Deep venous thrombosis: outpatient therapy with low-molecular-weight heparin.
    Tapson VF
    Manag Care; 1999 Dec; 8 Suppl():2-6. PubMed ID: 11729399
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-molecular-weight herapin.
    Whang PG; Lieberman JR
    J Am Acad Orthop Surg; 2002; 10(5):299-302. PubMed ID: 12374480
    [No Abstract]   [Full Text] [Related]  

  • 4. Treat DVT with low molecular weight heparin.
    Nadeau C; Varrone J
    Nurse Pract; 2003 Oct; 28(10):22-9; quiz 30-1. PubMed ID: 14560128
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent miscarriages: caution regarding development of clinical trials using low molecular weight heparin and pregnancy.
    Misra D; Aledort L
    Am J Hematol; 2011 Feb; 86(2):235. PubMed ID: 21264918
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-molecular-weight heparin in treatment of venous thromboembolism. An emerging theme.
    Hull RD; Pineo GF
    Int Angiol; 1998 Sep; 17(3):131-4. PubMed ID: 9821024
    [No Abstract]   [Full Text] [Related]  

  • 7. Clots and cancer.
    Ali SN; Stebbing J; Mazhar D
    Future Oncol; 2006 Dec; 2(6):647-9. PubMed ID: 17155891
    [No Abstract]   [Full Text] [Related]  

  • 8. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 9. The optimal long-term treatment of venous thromboembolism.
    Prandoni P
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):729-32. PubMed ID: 16170889
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.
    Hirsh J; Warkentin TE; Shaughnessy SG; Anand SS; Halperin JL; Raschke R; Granger C; Ohman EM; Dalen JE
    Chest; 2001 Jan; 119(1 Suppl):64S-94S. PubMed ID: 11157643
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on the clinical use of the low-molecular-weight heparin, parnaparin.
    Camporese G; Bernardi E; Noventa F
    Vasc Health Risk Manag; 2009; 5():819-31. PubMed ID: 19851520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
    Hirsh J; Warkentin TE; Raschke R; Granger C; Ohman EM; Dalen JE
    Chest; 1998 Nov; 114(5 Suppl):489S-510S. PubMed ID: 9822059
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy.
    Thomson AJ; Walker ID; Greer IA
    Lancet; 1998 Dec; 352(9144):1904. PubMed ID: 9863791
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of long-term anticoagulant therapy on levels of circulating microparticles in patients with deep venous thrombosis.
    Otero R; Elias T; Montes-Worboys A; Dawson G; Lampa R; Jara L; Scully M
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):628-9. PubMed ID: 21959591
    [No Abstract]   [Full Text] [Related]  

  • 15. New-generation anticoagulants: the low molecular weight heparins.
    Hovanessian HC
    Ann Emerg Med; 1999 Dec; 34(6):768-79. PubMed ID: 10577408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Harrington DW; Jindeel A
    JAMA; 2007 Jan; 297(3):262; author reply 263. PubMed ID: 17227972
    [No Abstract]   [Full Text] [Related]  

  • 17. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Zhan H; Zheng H
    JAMA; 2007 Jan; 297(3):261-2; author reply 263. PubMed ID: 17227970
    [No Abstract]   [Full Text] [Related]  

  • 18. Home treatment and secondary prevention of deep vein thrombosis.
    Prandoni P; Mosena L
    Haematologica; 2001 Nov; 86(11 Suppl 2):49-53. PubMed ID: 11926778
    [No Abstract]   [Full Text] [Related]  

  • 19. Low molecular weight heparins: are they interchangeable? No.
    Nenci GG
    J Thromb Haemost; 2003 Jan; 1(1):12-3. PubMed ID: 12871532
    [No Abstract]   [Full Text] [Related]  

  • 20. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Bhala N; Shah A; King A; Molugu C
    JAMA; 2007 Jan; 297(3):261; author reply 263. PubMed ID: 17227971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.